Riyasat Ali

Riyasat Ali

Auto-generated profile, based on publicly available information

Riyasat Ali

Department of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Molecular Immunology
Verified
Journal Article
Closed access
SKSudhir Kumar
Sudhir Kumar
RNRaza Ali Naqvi
Raza Ali Naqvi
RARiyasat Ali
Riyasat Ali
RRRicha Rani
Richa Rani
NKNeena Khanna
Neena Khanna
DRD.N. Rao
D.N. Rao

1 January 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SPSanket N. Patel
Sanket N. Patel
NFNaureen Fatima
Naureen Fatima
RARiyasat Ali
Riyasat Ali
THTahir Hussain
Tahir Hussain
The hyperactive RAS and inflammation are closely associated. The angiotensin-II/AT1R axis of the RAS has been explored extensively for its role in inflammation and a plethora of pathological conditions. Understanding the role of AT2R in inflammation is an emerging area of research. The AT2R is expressed on a variety of immune and non-immune cells, which upon activation triggers the release of a host of cytokines and has multiple effects that coalesce to anti-inflammation and prevents maladaptive repair. The anti-inflammatory outcomes of AT2R activation are linked to its well-established signaling pathways involving formation of nitric oxide and activation of phosphatases. Collectively, these effects promote cell survival and tissue function. The consideration of AT2R as a therapeutic target requires further investigations.

1 December 2013 in Immunobiology
Verified
Journal Article
Closed access
SKSudhir Kumar
Sudhir Kumar
RNRaza Ali Naqvi
Raza Ali Naqvi
ABAjaz Bhat
Ajaz Bhat
RRRicha Rani
Richa Rani
RARiyasat Ali
Riyasat Ali
DRD.N. Rao
D.N. Rao

11 November 2013 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SKSudhir Kumar
Sudhir Kumar
RNRaza Ali Naqvi
Raza Ali Naqvi
RARiyasat Ali
Riyasat Ali
RRRicha Rani
Richa Rani
NKNeena Khanna
Neena Khanna
DRD. N. Rao
D. N. Rao
Leprosy is a chronic infectious disease caused by Mycobacterium leprae. FoxP3 have been shown to have important implications in various diseases. The present study describes the mechanism of action of FoxP3 in CD4+CD25+ T cells derived from leprosy patients. Increased molecular interactions of FoxP3 with histone deacetylases 7/9 in the nucleus of CD4+CD25+ T cells derived from borderline lepromatous leprosy/lepromatous leprosy (BL/LL) patients were found to be responsible for FoxP3‐driven immune suppression activities during the progression of leprosy. Further, downregulation of CTLA‐4 and CD25 genes in siFoxP3‐treated PBMCs derived from BL/LL patients elucidated the transcription‐activating nature of FoxP3. This observation was supported by direct binding of FoxP3 to the promoter region of the CTLA‐4 and CD25 genes, and FoxP3's molecular interaction with histone acetyl transferases. The study also revealed that the increased expression of miR155 in CD4+CD25+ cells from BL/LL governs the competitive fitness of these cells. Again, reduced Annexin V & propidium iodide staining and Nur77 expression, and concomitantly increased Ki‐67 positivity suggested that CD4+CD25+ cells derived from BL/LL patients are more competitively fit than those from borderline tuberculoid leprosy/tuberculoid leprosy and healthy controls. Taken together, the study shows the orchestration of FoxP3 leading to competitive fitness of Treg cells in leprosy.

15 May 2018 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JSJennifer Schloss
Jennifer Schloss
RARiyasat Ali
Riyasat Ali
JRJeremy J. Racine
Jeremy J. Racine
HCHarold D. Chapman
Harold D. Chapman
DSDavid V. Serreze
David V. Serreze
TDTeresa P. DiLorenzo
Teresa P. DiLorenzo
Type 1 diabetes (T1D) is characterized by T cell–mediated destruction of the insulin-producing β cells of the pancreatic islets. Among the loci associated with T1D risk, those most predisposing are found in the MHC region. HLA-B*39:06 is the most predisposing class I MHC allele and is associated with an early age of onset. To establish an NOD mouse model for the study of HLA-B*39:06, we expressed it in the absence of murine class I MHC. HLA-B*39:06 was able to mediate the development of CD8 T cells, support lymphocytic infiltration of the islets, and confer T1D susceptibility. Because reduced thymic insulin expression is associated with impaired immunological tolerance to insulin and increased T1D risk in patients, we incorporated this in our model as well, finding that HLA-B*39:06–transgenic NOD mice with reduced thymic insulin expression have an earlier age of disease onset and a higher overall prevalence as compared with littermates with typical thymic insulin expression. This was despite virtually indistinguishable blood insulin levels, T cell subset percentages, and TCR Vβ family usage, confirming that reduced thymic insulin expression does not impact T cell development on a global scale. Rather, it will facilitate the thymic escape of insulin-reactive HLA-B*39:06–restricted T cells, which participate in β cell destruction. We also found that in mice expressing either HLA-B*39:06 or HLA-A*02:01 in the absence of murine class I MHC, HLA transgene identity alters TCR Vβ usage by CD8 T cells, demonstrating that some TCR Vβ families have a preference for particular class I MHC alleles.

1 January 2010 in Immunological Investigations
Verified
Journal Article
Closed access
PDF file
ABAjaz Bhat
Ajaz Bhat
RSRatanesh Seth
Ratanesh Seth
SKSudhir Kumar
Sudhir Kumar
RARiyasat Ali
Riyasat Ali
TMTeena Mohan
Teena Mohan
DRD. N. Rao
D. N. Rao
T-cells play a critical role in resistance to malaria, not only because they function as helper cells for an antibody response, but also because they serve as effector cells. Such cellular immunity is directly implicated in protection from sporozoites as well as from blood stage parasites. The aim of this study was to induce cell mediated immune responses to peptide antigens of Plasmodium vivax co-encapsulated with CpG oligodeoxynucleotide (ODN) in microparticles. In the present study, we have investigated the immunomodulatory effects of two CpG adjuvants, CpG 1826 and CpG 2006 to the five peptide antigens of Plasmodium vivax derived from circumsporozoite protein, merozoite surface protein-1, apical membrane antigen-1 and gametocyte surface antigen (Pvs24) in microparticle delivery. The T-cell proliferation response study of the cells collected from spleen, lamina propria and peyer's patches showed significantly high (p<0.001) stimulation index when primed with peptide antigens in microparticles co-encapsulating CpG ODN adjuvant as compared to peptide alone primed mice. The cytokine measurement profile of IFN-γ, TNF-α, IL-2, IL-4 and IL-10 in culture supernatants of cells primed with peptide antigens in microparticles co-encapsulating CpG ODN showed higher levels of IFN- γ followed by TNF-α and IL-2, with relatively low levels of IL-4 and IL-10.